Exact Mass: 353.9674

Exact Mass Matches: 353.9674

Found 28 metabolites which its exact mass value is equals to given mass value 353.9674, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Pipobroman

3-bromo-1-[4-(3-bromopropanoyl)piperazin-1-yl]propan-1-one

C10H16Br2N2O2 (353.9578)


Pipobroman is only found in individuals that have used or taken this drug. It is an antineoplastic agent that acts by alkylation. [PubChem]The mechanism of action is uncertain but pipobroman is thought to alkylate DNA leading to disruption of DNA synthesis and eventual cell death. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01A - Alkylating agents C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D009676 - Noxae > D000477 - Alkylating Agents D000970 - Antineoplastic Agents

   

idoxuridine

idoxuridine

C9H11IN2O5 (353.9713)


J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use > D06BB - Antivirals S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AD - Antivirals D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent Idoxuridine (5-Iodo-2′-deoxyuridine, 5-IUdR, IdUrd) is an iodinated thymidine analogue that competitively inhibits phosphorylases. Idoxuridine can inhibit viral activity, particularly viral eye infections, including herpes simplex keratitis, by inhibiting DNA polymerase and affecting viral replication. Idoxuridine against feline herpesvirus has the IC50 value of 4.3 μM[1]. Idoxuridine shows anti-orthopoxvirus activity.

   

Idoxuridine

1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodo-1,2,3,4-tetrahydropyrimidine-2,4-dione

C9H11IN2O5 (353.9713)


Idoxuridine is only found in individuals that have used or taken this drug. It is an analog of deoxyuridine that inhibits viral DNA synthesis. The drug is used as an antiviral agent. [PubChem]Idoxuridine acts as an antiviral agent by inhibiting viral replication by substituting itself for thymidine in viral DNA. This in turn inhibits thymidylate phosphorylase and viral DNA polymerases from properly functioning. The effect of Idoxuridine results in the inability of the virus to reproduce or to infect/destroy tissue. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use > D06BB - Antivirals S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AD - Antivirals D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent Idoxuridine (5-Iodo-2′-deoxyuridine, 5-IUdR, IdUrd) is an iodinated thymidine analogue that competitively inhibits phosphorylases. Idoxuridine can inhibit viral activity, particularly viral eye infections, including herpes simplex keratitis, by inhibiting DNA polymerase and affecting viral replication. Idoxuridine against feline herpesvirus has the IC50 value of 4.3 μM[1]. Idoxuridine shows anti-orthopoxvirus activity.

   

Dendrid

1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodo-1,2,3,4-tetrahydropyrimidine-2,4-dione

C9H11IN2O5 (353.9713)


   

5'-Iododeoxyuridine

1-{4-hydroxy-5-[hydroxy(iodo)methyl]oxolan-2-yl}-1,2,3,4-tetrahydropyrimidine-2,4-dione

C9H11IN2O5 (353.9713)


   

Diphosphoglucuronic acid

2,3,4-trihydroxy-5-{[hydroxy(phosphonooxy)phosphoryl]oxy}-6-oxohexanoic acid

C6H12O13P2 (353.9753)


   

(2S,4R,5S)-4,5,6-Trihydroxy-2-[hydroxy(phosphonooxy)phosphoryl]oxy-3-oxohexanoic acid

(2S,4R,5S)-4,5,6-Trihydroxy-2-[hydroxy(phosphonooxy)phosphoryl]oxy-3-oxohexanoic acid

C6H12O13P2 (353.9753)


   

6-Bromogranulatimide

6-Bromogranulatimide

C15H7BrN4O2 (353.9752)


   

Carbamic acid, (2-chloro-3-iodo-4-pyridinyl)-, 1,1-dimethylethyl ester (9CI)

Carbamic acid, (2-chloro-3-iodo-4-pyridinyl)-, 1,1-dimethylethyl ester (9CI)

C10H12ClIN2O2 (353.9632)


   

2-{[(4-Bromophenyl)sulfonyl]amino}benzamide

2-{[(4-Bromophenyl)sulfonyl]amino}benzamide

C13H11BrN2O3S (353.9674)


   

4,5-diamino-2-(4-bromo-2-chloroanilino)-3-fluorobenzonitrile

4,5-diamino-2-(4-bromo-2-chloroanilino)-3-fluorobenzonitrile

C13H9BrClFN4 (353.9683)


   

4-(4-IODO-PHENOXY)-BENZOIC ACID METHYL ESTER

4-(4-IODO-PHENOXY)-BENZOIC ACID METHYL ESTER

C14H11IO3 (353.9753)


   

3-(4-BROMO-2-CHLOROPHENOXYMETHYL)-4-METHOXYBENZALDEHYDE

3-(4-BROMO-2-CHLOROPHENOXYMETHYL)-4-METHOXYBENZALDEHYDE

C15H12BrClO3 (353.9658)


   

terbium acetate hydrate/

terbium acetate hydrate/

C6H11O7Tb (353.9758)


   

Benzyl 2-hydroxy-5-iodobenzoate

Benzyl 2-hydroxy-5-iodobenzoate

C14H11IO3 (353.9753)


   

tert-Butyl (6-chloro-4-iodopyridin-3-yl)carbamate

tert-Butyl (6-chloro-4-iodopyridin-3-yl)carbamate

C10H12ClIN2O2 (353.9632)


   

tert-butyl N-(2-chloro-4-iodopyridin-3-yl)carbamate

tert-butyl N-(2-chloro-4-iodopyridin-3-yl)carbamate

C10H12ClIN2O2 (353.9632)


   

Terbium(Iii) Acetate Hydrate

Terbium(Iii) Acetate Hydrate

C6H11O7Tb (353.9758)


   

3-(2-BROMO-4-CHLOROPHENOXYMETHYL)-4-METHOXYBENZALDEHYDE

3-(2-BROMO-4-CHLOROPHENOXYMETHYL)-4-METHOXYBENZALDEHYDE

C15H12BrClO3 (353.9658)


   

(4-BROMO-2,6-DICHLOROPHENOXY)(TERT-BUTYL)DIMETHYLSILANE

(4-BROMO-2,6-DICHLOROPHENOXY)(TERT-BUTYL)DIMETHYLSILANE

C12H17BrCl2OSi (353.9609)


   

5-Deoxy-5-iodouridine

5-Deoxy-5-iodouridine

C9H11IN2O5 (353.9713)


5'-Deoxy-5'-iodouridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

   

Uridine, 2-deoxy-5-iodo-

1-[(2R,5R)-4-hydroxy-5-(hydroxymethyl)-2-oxolanyl]-5-iodopyrimidine-2,4-dione

C9H11IN2O5 (353.9713)


D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents

   

2,4-Dihydroxy-3-oxo-5-phosphonooxy-2-(phosphonooxymethyl)pentanoic acid

2,4-Dihydroxy-3-oxo-5-phosphonooxy-2-(phosphonooxymethyl)pentanoic acid

C6H12O13P2 (353.9753)


   

2,3,4-Trihydroxy-5-[hydroxy(phosphonooxy)phosphoryl]oxy-6-oxohexanoic acid

2,3,4-Trihydroxy-5-[hydroxy(phosphonooxy)phosphoryl]oxy-6-oxohexanoic acid

C6H12O13P2 (353.9753)


   

(2S,4R,5S)-4,5,6-Trihydroxy-2-[hydroxy(phosphonooxy)phosphoryl]oxy-3-oxohexanoic acid

(2S,4R,5S)-4,5,6-Trihydroxy-2-[hydroxy(phosphonooxy)phosphoryl]oxy-3-oxohexanoic acid

C6H12O13P2 (353.9753)


   

pipobroman

pipobroman

C10H16Br2N2O2 (353.9578)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01A - Alkylating agents C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D009676 - Noxae > D000477 - Alkylating Agents D000970 - Antineoplastic Agents

   

1-[(2R,5R)-4-hydroxy-5-(hydroxymethyl)-2-oxolanyl]-5-iodopyrimidine-2,4-dione

1-[(2R,5R)-4-hydroxy-5-(hydroxymethyl)-2-oxolanyl]-5-iodopyrimidine-2,4-dione

C9H11IN2O5 (353.9713)


   

16-bromo-10-hydroxy-3,5,9,19-tetraazapentacyclo[10.7.0.0²,⁶.0⁷,¹¹.0¹³,¹⁸]nonadeca-1(12),2(6),4,7(11),9,13(18),14,16-octaen-8-one

16-bromo-10-hydroxy-3,5,9,19-tetraazapentacyclo[10.7.0.0²,⁶.0⁷,¹¹.0¹³,¹⁸]nonadeca-1(12),2(6),4,7(11),9,13(18),14,16-octaen-8-one

C15H7BrN4O2 (353.9752)